The US Centers for Disease Control and Prevention (CDC) announced the launch of a new study to detect and better understand acute febrile illnesses (AFIs) in Belize, Guatemala, and the Dominican Republic.
The Food and Drug Administration (FDA) approved the use single-dose Xofluza (baloxavir marboxil) for patients ages 12 and over who are at high risk for influenza complications. Xofluza should only be administered to patients who have been symptomatic for 48 hours or less.
Today the World Health Organization (WHO) dashboard shows 3 new Ebola cases in the Democratic Republic of the Congo (DRC), which raise the outbreak total to 3,194 cases, including 2,133 deaths. A total of 346 suspected cases are still under investigation.
Also today the DRC’s multisector Ebola committee (CMRE) said three cases yesterday originated in Kalunguta, Mambasa, and Mandima—all current virus hot spots.
A task force will identify priorities and monitor progress, and HHS will coordinate efforts.
They say the world is not prepared for a pandemic.
California Governor Gavin Newsom yesterday signed two bills that limit medical exemptions for vaccines in schoolchildren.
Researchers find no difference in health worker infections from flu, other viruses.
Countries in the Americas have reported a 70% increase in the number of measles cases since mid June, according to an update yesterday from the Pan American Health Organization (PAHO).
Ebola infections have been reported in 10 more people in the Democratic Republic of the Congo (DRC) outbreak, raising the total to 2,630, according to the World Health Organization (WHO) online dashboard today. Health officials are still investigating 344 suspected cases.
President Trump yesterday signed bipartisan legislation reauthorizing the Pandemic and All-Hazards Preparedness and Advancing Innovations Act (PAHPA), which plays a crucial role in preparing the country for natural or manmade biological threats such as pandemic flu or a bioterror attack.
